Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis An Official American Thoracic Society Research Statement

Catherine Sears, M. Patricia Rivera, Philippe Camus, Mina Gaga, Edward B. Garon, Michael K. Gould, Andrew H. Limper, Philippe R. Montgrain, Jarushka Naidoo, Mizuki Nishino, Sandip P. Patel, Tobias Peikert, Jennifer D. Possick, William D. Travis

Research output: Contribution to journalArticle

Abstract

Rationale: Immune checkpoint inhibitors (ICIs) have revolutionized cancer care but are associated with unique adverse events, including potentially life-threatening pneumonitis. The diagnosis of ICI-pneumonitis is increasing; however, the biological mechanisms, clinical and radiologic features, and the diagnosis and management have not been well defined. Objectives: To summarize evidence, identify knowledge and research gaps, and prioritize topics and propose methods for future research on ICI-pneumonitis. Methods: A multidisciplinary group of international clinical researchers reviewed available data on ICI-pneumonitis to develop and refine research questions pertaining to ICI-pneumonitis. Results: This statement identifies gaps in knowledge and develops potential research questions to further expand knowledge regarding risk, biologic mechanisms, clinical and radiologic presentation, and management of ICI-pneumonitis. Conclusions: Gaps in knowledge of the basic biological mechanisms of ICI-pneumonitis, coupled with a precipitous increase in the use of ICIs alone or combined with other therapies, highlight the importance in triaging research priorities for ICI-pneumonitis.

Original languageEnglish (US)
Pages (from-to)E31-E43
JournalAmerican journal of respiratory and critical care medicine
Volume200
Issue number6
DOIs
StatePublished - Sep 15 2019

Fingerprint

Pneumonia
Research
Research Personnel
Neoplasms

Keywords

  • Immunotherapy
  • Interstitial lung disease
  • Lung cancer
  • NSCLC

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis An Official American Thoracic Society Research Statement. / Sears, Catherine; Rivera, M. Patricia; Camus, Philippe; Gaga, Mina; Garon, Edward B.; Gould, Michael K.; Limper, Andrew H.; Montgrain, Philippe R.; Naidoo, Jarushka; Nishino, Mizuki; Patel, Sandip P.; Peikert, Tobias; Possick, Jennifer D.; Travis, William D.

In: American journal of respiratory and critical care medicine, Vol. 200, No. 6, 15.09.2019, p. E31-E43.

Research output: Contribution to journalArticle

Sears, C, Rivera, MP, Camus, P, Gaga, M, Garon, EB, Gould, MK, Limper, AH, Montgrain, PR, Naidoo, J, Nishino, M, Patel, SP, Peikert, T, Possick, JD & Travis, WD 2019, 'Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis An Official American Thoracic Society Research Statement', American journal of respiratory and critical care medicine, vol. 200, no. 6, pp. E31-E43. https://doi.org/10.1164/rccm.201906-1202ST
Sears, Catherine ; Rivera, M. Patricia ; Camus, Philippe ; Gaga, Mina ; Garon, Edward B. ; Gould, Michael K. ; Limper, Andrew H. ; Montgrain, Philippe R. ; Naidoo, Jarushka ; Nishino, Mizuki ; Patel, Sandip P. ; Peikert, Tobias ; Possick, Jennifer D. ; Travis, William D. / Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis An Official American Thoracic Society Research Statement. In: American journal of respiratory and critical care medicine. 2019 ; Vol. 200, No. 6. pp. E31-E43.
@article{957e23833ac84ffe8d1ace085766f9cf,
title = "Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis An Official American Thoracic Society Research Statement",
abstract = "Rationale: Immune checkpoint inhibitors (ICIs) have revolutionized cancer care but are associated with unique adverse events, including potentially life-threatening pneumonitis. The diagnosis of ICI-pneumonitis is increasing; however, the biological mechanisms, clinical and radiologic features, and the diagnosis and management have not been well defined. Objectives: To summarize evidence, identify knowledge and research gaps, and prioritize topics and propose methods for future research on ICI-pneumonitis. Methods: A multidisciplinary group of international clinical researchers reviewed available data on ICI-pneumonitis to develop and refine research questions pertaining to ICI-pneumonitis. Results: This statement identifies gaps in knowledge and develops potential research questions to further expand knowledge regarding risk, biologic mechanisms, clinical and radiologic presentation, and management of ICI-pneumonitis. Conclusions: Gaps in knowledge of the basic biological mechanisms of ICI-pneumonitis, coupled with a precipitous increase in the use of ICIs alone or combined with other therapies, highlight the importance in triaging research priorities for ICI-pneumonitis.",
keywords = "Immunotherapy, Interstitial lung disease, Lung cancer, NSCLC",
author = "Catherine Sears and Rivera, {M. Patricia} and Philippe Camus and Mina Gaga and Garon, {Edward B.} and Gould, {Michael K.} and Limper, {Andrew H.} and Montgrain, {Philippe R.} and Jarushka Naidoo and Mizuki Nishino and Patel, {Sandip P.} and Tobias Peikert and Possick, {Jennifer D.} and Travis, {William D.}",
year = "2019",
month = "9",
day = "15",
doi = "10.1164/rccm.201906-1202ST",
language = "English (US)",
volume = "200",
pages = "E31--E43",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis An Official American Thoracic Society Research Statement

AU - Sears, Catherine

AU - Rivera, M. Patricia

AU - Camus, Philippe

AU - Gaga, Mina

AU - Garon, Edward B.

AU - Gould, Michael K.

AU - Limper, Andrew H.

AU - Montgrain, Philippe R.

AU - Naidoo, Jarushka

AU - Nishino, Mizuki

AU - Patel, Sandip P.

AU - Peikert, Tobias

AU - Possick, Jennifer D.

AU - Travis, William D.

PY - 2019/9/15

Y1 - 2019/9/15

N2 - Rationale: Immune checkpoint inhibitors (ICIs) have revolutionized cancer care but are associated with unique adverse events, including potentially life-threatening pneumonitis. The diagnosis of ICI-pneumonitis is increasing; however, the biological mechanisms, clinical and radiologic features, and the diagnosis and management have not been well defined. Objectives: To summarize evidence, identify knowledge and research gaps, and prioritize topics and propose methods for future research on ICI-pneumonitis. Methods: A multidisciplinary group of international clinical researchers reviewed available data on ICI-pneumonitis to develop and refine research questions pertaining to ICI-pneumonitis. Results: This statement identifies gaps in knowledge and develops potential research questions to further expand knowledge regarding risk, biologic mechanisms, clinical and radiologic presentation, and management of ICI-pneumonitis. Conclusions: Gaps in knowledge of the basic biological mechanisms of ICI-pneumonitis, coupled with a precipitous increase in the use of ICIs alone or combined with other therapies, highlight the importance in triaging research priorities for ICI-pneumonitis.

AB - Rationale: Immune checkpoint inhibitors (ICIs) have revolutionized cancer care but are associated with unique adverse events, including potentially life-threatening pneumonitis. The diagnosis of ICI-pneumonitis is increasing; however, the biological mechanisms, clinical and radiologic features, and the diagnosis and management have not been well defined. Objectives: To summarize evidence, identify knowledge and research gaps, and prioritize topics and propose methods for future research on ICI-pneumonitis. Methods: A multidisciplinary group of international clinical researchers reviewed available data on ICI-pneumonitis to develop and refine research questions pertaining to ICI-pneumonitis. Results: This statement identifies gaps in knowledge and develops potential research questions to further expand knowledge regarding risk, biologic mechanisms, clinical and radiologic presentation, and management of ICI-pneumonitis. Conclusions: Gaps in knowledge of the basic biological mechanisms of ICI-pneumonitis, coupled with a precipitous increase in the use of ICIs alone or combined with other therapies, highlight the importance in triaging research priorities for ICI-pneumonitis.

KW - Immunotherapy

KW - Interstitial lung disease

KW - Lung cancer

KW - NSCLC

UR - http://www.scopus.com/inward/record.url?scp=85072155928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072155928&partnerID=8YFLogxK

U2 - 10.1164/rccm.201906-1202ST

DO - 10.1164/rccm.201906-1202ST

M3 - Article

C2 - 31518182

AN - SCOPUS:85072155928

VL - 200

SP - E31-E43

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6

ER -